1. bookVolume 15 (2022): Edizione 1 (June 2022)
Dettagli della rivista
License
Formato
Rivista
eISSN
1313-9053
Prima pubblicazione
08 Sep 2014
Frequenza di pubblicazione
2 volte all'anno
Lingue
Inglese
Open Access

Two Clinical Cases of Secondary Neoplasia After Remission of Hodgkin’s Disease

Pubblicato online: 13 Jul 2022
Volume & Edizione: Volume 15 (2022) - Edizione 1 (June 2022)
Pagine: 83 - 86
Ricevuto: 01 Dec 2021
Accettato: 10 Feb 2022
Dettagli della rivista
License
Formato
Rivista
eISSN
1313-9053
Prima pubblicazione
08 Sep 2014
Frequenza di pubblicazione
2 volte all'anno
Lingue
Inglese

1. Hjalgrim H, Jarrett RF. Epidemiology of Hodgkin Lymphoma. In: Engert A., Younes A. (eds) Hodgkin Lymphoma. Hematologic Malignancies. Springer, Cham, 2020.10.1007/978-3-030-32482-7_1 Search in Google Scholar

2. Westin RJ, Gibbs A, Mills RK, Neelapu SS. Hodgkin Lymphoma Untreated for Six Years Presenting with Tracheoesophageal Fistula. Volume 2012, Article ID 45790810.1155/2012/457908339541322811723 Search in Google Scholar

3. Gaudio F, Pedote P, Niccoli Asabella A, Ingravallo G, Sindaco P, Alberotanza V, Perrone T et al. Bone involvement in Hodgkin‘s lymphoma: clinical features and outcome. ActaHaematol 2018;140:178-82.10.1159/00049048930300883 Search in Google Scholar

4. Mottok A, Steidl Ch. Biology of classical Hodgkin lymphoma: implications for prognosis and novel therapies. Blood 2018;131(15):1654-65.10.1182/blood-2017-09-77263229500175 Search in Google Scholar

5. Risk Factors: Age - National Cancer Institutehttps://www.cancer.gov Search in Google Scholar

6. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC. Second cancer risk after chemotherapy for Hodgkin’s lymphoma: a collaborative British cohort study. J ClinOncol. 2011 Nov 1;29(31):4096-104.10.1200/JCO.2011.34.826821969511 Search in Google Scholar

7. Hjalgrim H, Jarrett RF. Epidemiology of Hodgkin Lymphoma. In: Engert A., Younes A. (eds) Hodgkin Lymphoma. Hematologic Malignancies. Springer, Cham, 2020.10.1007/978-3-030-32482-7_1 Search in Google Scholar

8. Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS. Occurrence of Non-Hodgkin’s Lymphoma after Therapy for Hodgkin’s Disease. New England Journal of Medicine. 1979;300(9):452-8.10.1056/NEJM197903013000902366418 Search in Google Scholar

9. Schaapveld M, Aleman PMB, van Eggermond A, Janus MPC, Krol GDA, van der Maazen MWR et al. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma. N Engl J Med 2015; 373:2499-511.10.1056/NEJMoa150594926699166 Search in Google Scholar

10. Bakkach J, Mansouri M, Loudiyi A, Nourouti NG, Barakat A, Mechita MB. Secondary breast cancer after Hodgkin lymphoma: a case report and literature review. Ecancermedicalscience. 2018 Feb 14;12:810.10.3332/ecancer.2018.810582867329492104 Search in Google Scholar

11. Opstal-van Winden AWJ, de Haan HG, Hauptmann M, Schmidt MK, Broeks A, Russell NS, et al. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma. Blood. 2019 Mar 7;133(10):1130-9.10.1182/blood-2018-07-862607640533430573632 Search in Google Scholar

12. Sud A, Thomsen H, Sundquist K, Houlston S R, Hemminki K. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History. J Clin Oncol. 2017;35(14):1584-90.10.1200/JCO.2016.70.9709545570528384078 Search in Google Scholar

13. Schellong G, Riepenhausen M, Ehlert K, Brämswig J, Dörffel W, Schmutzler RK, et al. Breast cancer in young women after treatment for Hodgkin‘s disease during childhood or adolescence - an observational study with up to 33-year follow-up. Dtsch Arztebl Int. 2014;111(1-2):3-9.10.3238/arztebl.2014.0003394801324565270 Search in Google Scholar

14. Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M. Risk of second breast cancer in female Hodgkin‘s lymphoma survivors: a meta-analysis. BMC Cancer. 2012;12:197.10.1186/1471-2407-12-197341658522639888 Search in Google Scholar

15. van Leeuwen FE, Ng AK. Late sequelae in Hodgkin lymphoma survivors. Hematol Oncol. 2017 Jun;35 Suppl 1:60-66.10.1002/hon.240228591411 Search in Google Scholar

16. Horst KC, Hancock SL, Ognibene G, Chen C, Advani RH, Rosenberg SA, Donaldson SS, Hoppe RT. Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma. Ann Oncol. 2014 Apr;25(4):848-51.10.1093/annonc/mdu01724608191 Search in Google Scholar

17. Engert A, Plütschow A, Eichth H, Lohri A, Dörken B, Borchmann P et al. Reduced Treatment Intensity in Patients with Early-Stage Hodgkin‘s Lymphoma. N Engl J Med 2010;363:640-52.10.1056/NEJMoa100006720818855 Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo